The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

PRNewswire New York [US] 13 Fourth Frontier a medical technology company based out of New York and Bangalore announced the ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

Varipulse devices developed by Johnson & Johnson MedTech (NYSE:JNJ) have been approved by the U.S. Food and Drug Administration for treating paroxysmal atrial fibrillation in individuals not ...

Exposure to temperatures of 100°F (38°C) or higher may nearly triple the number of episodes of a form of irregular heart ...

The Frontier X Plus is an innovative single-lead, continuous ECG monitor that is worn around the chest and wirelessly relays ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

We explore how wearable devices can help in monitoring and maintaining our health, and the challenges of integrating ...